Lymphatic Mapping Of Oropharyngeal Cancer
ConditionOropharyngeal Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity College, London
About this trial
A multi-centre validation study to evaluate whether a new imaging and surgical protocol would work as well as the current gold standard in identifying sentinel nodes in patients with oropharyngeal cancer.
Eligibility criteria
Qualifiers
Adults aged 18 or over
New diagnosis of OPC - all anatomical subsites and HPV status accepted
Unilateral metastatic nodes equating to AJCC TNM8 clinical staging N1-N2b for P16 negative and N1 for P16 positive patients.
Disqualifiers
Suspicious bilateral nodes on imaging
Previous radiotherapy or surgery to the neck
Second primary oropharyngeal tumours
Distant metastasis (e.g. lung, bone)
Trial design
Treatments tested in this trial
- Imaging procedure
- Surgical procedure
Treatment groups
150 Participants
are divided into 2 treatment groupsSponsors and collaborators
University College, London
Lead sponsor
National Institute for Health Research, United Kingdom
Collaborator
Source ClinicalTrials.gov